October 15, 2018 / 5:05 AM / a month ago

BRIEF-Santhera Gets Positive Opinion For Orphan Drug Designation In EU For Pol6014 In Cystic Fibrosis

Oct 15 (Reuters) - Santhera Pharmaceuticals Holding AG:

* SANTHERA RECEIVES POSITIVE OPINION FOR ORPHAN DRUG DESIGNATION IN THE EU FOR POL6014 IN CYSTIC FIBROSIS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below